文献速递产科母胎医学

孕早期母体肠道菌群与小脆弱新生儿的前瞻性队列研究

First‐Trimester Maternal Gut Microbiome and Small Vulnerable Newborns: A Prospective Cohort Study
RSS 订阅 · BJOG · 2026-11-04

在孟加拉国农村纳入213名孕早期妇女,采集血液和粪便样本并记录分娩后72小时内出生结局,用随机森林模型评估肠道菌群对SVN的预测能力。菌群模型区分SVN的AUC为0.653(95%CI 0.518–0.789),并可预测血浆α1-酸性糖蛋白和粪便钙卫蛋白;α1-酸性糖蛋白与SVN显著相关(aOR=1.98;95%CI 1.04–3.85),钙卫蛋白则无关。

要点

  • 孕早期肠道菌群对SVN的区分能力有限,AUC为0.653。
  • 菌群可预测α1-酸性糖蛋白和钙卫蛋白,提示菌群–炎症通路。
  • α1-酸性糖蛋白与SVN相关(aOR=1.98),钙卫蛋白无显著关联。

核心结论

  • 孕早期母体肠道菌群组成对SVN及全身炎症标志物仅有有限的区分能力,支持进一步研究早孕期菌群–炎症通路与胎儿生长受限和早产的关系。

研究设计与样本

  • 前瞻性队列研究,在孟加拉国农村纳入213名孕早期妇女,属NICHD全球网络妇女儿童健康登记研究的一部分。
  • 入组时采集血液和粪便样本,分娩后72小时内记录出生结局,用随机森林机器学习模型预测SVN及孕早期母体特征,并以留出集检验模型准确性。

主要发现

  • 菌群训练的随机森林模型区分SVN(n=106)与非SVN(n=107),AUC=0.653(95%CI 0.518–0.789)。
  • 菌群可预测血浆α1-酸性糖蛋白(AUC=0.742,95%CI 0.616–0.868)和粪便钙卫蛋白(AUC=0.793,95%CI 0.680–0.905)。
  • 微量营养素浓度、贫血、C反应蛋白及非典型肠致病性大肠杆菌存在未能被可靠预测。
  • α1-酸性糖蛋白升高与SVN显著相关(aOR=1.98;95%CI 1.04–3.85),钙卫蛋白与SVN无显著关联。

临床怎么用

  • 孕早期肠道菌群尚不足以单独作为SVN预测工具,不宜据此开展临床筛查。
  • 可将α1-酸性糖蛋白等炎症标志物作为后续研究早孕期菌群–炎症–不良出生结局通路的候选指标。

局限性

  • 单一人群(孟加拉国农村低收入地区)队列,外推性有限。
  • 菌群模型对SVN的区分能力有限(AUC=0.653),预测价值不高。
  • 观察性设计无法确立菌群与SVN之间的因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTRACT Objectives To investigate the relationship between the first trimester gut microbiome and small vulnerable newborns (SVN). Setting Rural low- and middle-income country: Bangladesh. Population 213 women were enrolled during the first trimester of pregnancy as part of the NICHD Global Network for Women's and Children's Health registry, Bangladesh. Methods Observational study of the maternal gut microbiome and birth outcomes. Blood and stool samples were collected at enrollment. Birth outcomes were recorded within 72 h of delivery. Random forest machine learning models trained on microbiome data were used to predict SVN or first-trimester maternal features of interest. Hold out sets were used to test model accuracy. Main Outcome Measures SVN (born preterm, low birth weight, or small for gestational age). Results The birth outcome SVN (n = 106) was discriminated from non-SVN (n = 107) using a microbiome-trained random forest model (AUC = 0.653, 95% CI 0.518–0.789). The microbiome also predicted the inflammatory markers plasma alpha-1-acid glycoprotein and faecal calprotectin (AUC = 0.742, 95% CI: 0.616–0.868 and AUC = 0.793, 95% CI: 0.680–0.905, respectively), while micronutrient concentrations, anaemia, C-reactive protein and the presence of atypical Enteropathogenic E. coli were not reliably predicted. Higher alpha-1-acid glycoprotein was significantly associated with SVN (aOR = 1.98; 95% CI: 1.04–3.85) whereas calprotectin was not. Conclusions In this prospective cohort, first-trimester maternal gut microbiome composition showed modest discrimination for SVN and a marker of systemic inflammation. These findings support further investigation of early pregnancy microbiome–inflammation pathways in fetal growth restriction and preterm birth.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. BJOG:First‐Trimester Maternal Gut Microbiome and Small Vulnerable Newborns: A Prospective Cohort Study

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。